Publication: Private Sector Pharmaceutical Supply and Distribution Channels in Africa : A Focus on Ghana, Malawi and Mali
dc.contributor.author | McCabe, Ariane | |
dc.contributor.author | Seiter, Andreas | |
dc.contributor.author | Diack, Aissatou | |
dc.contributor.author | Herbst, Christopher H. | |
dc.contributor.author | Dutta, Sheila | |
dc.contributor.author | Saleh, Karima | |
dc.date.accessioned | 2013-05-28T21:50:29Z | |
dc.date.available | 2013-05-28T21:50:29Z | |
dc.date.issued | 2011-08 | |
dc.description.abstract | Sustainable access to affordable, high-quality medicines is an important component in all health care systems but remains limited in many African countries. Supply and distribution of medicines are a fundamental aspect of the success of any health system. Disruptions to this supply undermine health outcomes as supply chains have an impact on the availability, cost, and quality of medicines for patients. Common problems associated with the supply and distribution of pharmaceuticals often include poor supply chain management, stock pilfering, insufficient human resources, and limited financing resulting in chronic stock outs. In resource-poor settings where public services fail to meet demand, the private and voluntary sectors are increasingly being called on, prompting some policy makers to consider private mechanisms as alternatives to state-run drug procurement and distribution systems. This study reviews some of the ways in which some countries in Africa organize their private pharmaceutical supply and distribution channels, focusing on three diverse countries: Ghana, Malawi, and Mali. It discusses some of the strengths and challenges associated with such arrangements, as well as relevant options to improve access, availability, quality and affordability of privately supplied pharmaceuticals. | en |
dc.identifier | http://documents.worldbank.org/curated/en/2011/08/15476296/private-sector-pharmaceutical-supply-distribution-channels-africa-focus-ghana-malawi-mali | |
dc.identifier.doi | 10.1596/13590 | |
dc.identifier.uri | https://hdl.handle.net/10986/13590 | |
dc.language | English | |
dc.language.iso | en_US | |
dc.publisher | World Bank, Washington, DC | |
dc.relation.ispartofseries | Health, Nutrition and Population (HNP) discussion paper; | |
dc.rights | CC BY 3.0 IGO | |
dc.rights.holder | World Bank | |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/igo/ | |
dc.subject | ACCESS TO PRODUCTS | |
dc.subject | ACCOUNTABILITY | |
dc.subject | ADVERTISING | |
dc.subject | ANALGESICS | |
dc.subject | ANTIMALARIALS | |
dc.subject | ARTISANS | |
dc.subject | ASPIRIN | |
dc.subject | BAR CODES | |
dc.subject | BATCH NUMBERS | |
dc.subject | BATCHES | |
dc.subject | BRAND | |
dc.subject | BRAND NAME | |
dc.subject | BRAND NAME PRODUCTS | |
dc.subject | BRAND NAMES | |
dc.subject | BRANDS | |
dc.subject | BUSINESS ENVIRONMENT | |
dc.subject | BUSINESS MODEL | |
dc.subject | BUSINESS MODELS | |
dc.subject | BUSINESS PARTNERS | |
dc.subject | BUSINESSES | |
dc.subject | BUYER | |
dc.subject | BUYERS | |
dc.subject | CAPABILITIES | |
dc.subject | CARTONS | |
dc.subject | CERTIFICATION | |
dc.subject | CHEMISTS | |
dc.subject | CLINICS | |
dc.subject | COLD CHAIN | |
dc.subject | COLLECTION OF DATA | |
dc.subject | COMMODITIES | |
dc.subject | COMMODITY | |
dc.subject | COMMUNICABLE DISEASES | |
dc.subject | COMMUNITY DEVELOPMENT | |
dc.subject | COMPETITIVENESS | |
dc.subject | COMPUTER SYSTEMS | |
dc.subject | CONSUMER DEMAND | |
dc.subject | CONSUMER EDUCATION | |
dc.subject | CONSUMER PRICES | |
dc.subject | CORRUPTION | |
dc.subject | DELIVERY SERVICES | |
dc.subject | DELIVERY SYSTEM | |
dc.subject | DIABETES | |
dc.subject | DISCLOSURE | |
dc.subject | DISTRIBUTION CHANNEL | |
dc.subject | DISTRIBUTION CHANNELS | |
dc.subject | DISTRIBUTION NETWORK | |
dc.subject | DISTRIBUTION OF PHARMACEUTICALS | |
dc.subject | DISTRIBUTION SYSTEM | |
dc.subject | DISTRIBUTION SYSTEMS | |
dc.subject | DOMESTIC MANUFACTURERS | |
dc.subject | DRUG DONATIONS | |
dc.subject | DRUG TESTING | |
dc.subject | DRUGS | |
dc.subject | ECONOMIC DEVELOPMENT | |
dc.subject | ELECTRICITY | |
dc.subject | ELECTRONIC PAYMENT | |
dc.subject | ELECTRONIC PROCUREMENT | |
dc.subject | EQUIPMENT | |
dc.subject | ESSENTIAL DRUGS | |
dc.subject | EXPENDITURE | |
dc.subject | EXPENDITURES | |
dc.subject | FAIR | |
dc.subject | FINANCIAL INSTITUTIONS | |
dc.subject | FINANCIAL INVESTMENT | |
dc.subject | FINANCIAL SERVICE | |
dc.subject | FINANCIAL SERVICES | |
dc.subject | FINANCIAL SUPPORT | |
dc.subject | FINISHED PRODUCTS | |
dc.subject | FLOW OF GOODS | |
dc.subject | FLOW OF INFORMATION | |
dc.subject | FOREIGN CURRENCY | |
dc.subject | FOREIGN EXCHANGE | |
dc.subject | GENERIC DRUGS | |
dc.subject | GENERIC PRODUCTS | |
dc.subject | GOOD MANUFACTURING PRACTICES | |
dc.subject | GOVERNMENT CONTRACTS | |
dc.subject | GOVERNMENT POLICIES | |
dc.subject | GOVERNMENT POLICY | |
dc.subject | GOVERNMENT SERVICES | |
dc.subject | HARMONIZATION | |
dc.subject | HEALTH CARE | |
dc.subject | HEALTH CARE WORKERS | |
dc.subject | HEALTH INSURANCE | |
dc.subject | HEALTH OUTCOMES | |
dc.subject | HEALTH SERVICES | |
dc.subject | HOSPITALIZATION | |
dc.subject | HOSPITALS | |
dc.subject | HUMAN RESOURCES | |
dc.subject | HYPERTENSION | |
dc.subject | INSPECTION | |
dc.subject | INSPECTIONS | |
dc.subject | INTERNATIONAL ACTORS | |
dc.subject | INTERNATIONAL COMPANIES | |
dc.subject | INTERNATIONAL ORGANIZATIONS | |
dc.subject | INVENTORIES | |
dc.subject | IRRATIONAL USE | |
dc.subject | LABORATORIES | |
dc.subject | LAWS | |
dc.subject | LEGAL SYSTEMS | |
dc.subject | LICENSE | |
dc.subject | LICENSES | |
dc.subject | LIFE EXPECTANCY | |
dc.subject | LIMITED ACCESS | |
dc.subject | LOCAL MANUFACTURERS | |
dc.subject | LOGISTICS COMPANIES | |
dc.subject | LOGISTICS SYSTEM | |
dc.subject | MARKET COMPETITION | |
dc.subject | MARKET FAILURES | |
dc.subject | MARKET FORCES | |
dc.subject | MARKET INFORMATION | |
dc.subject | MARKET RESEARCH | |
dc.subject | MARKET SHARE | |
dc.subject | MARKET STUDIES | |
dc.subject | MARKET VALUE | |
dc.subject | MARKETING | |
dc.subject | MATERIAL | |
dc.subject | MEDICAL STORES | |
dc.subject | MEDICAL SUPPLIES | |
dc.subject | MEDICINE | |
dc.subject | MEDICINES | |
dc.subject | MIDDLEMEN | |
dc.subject | MORTALITY | |
dc.subject | NEW MARKETS | |
dc.subject | NEW TECHNOLOGIES | |
dc.subject | NURSES | |
dc.subject | NUTRITION | |
dc.subject | PACKAGING | |
dc.subject | PARASTATALS | |
dc.subject | PATIENT | |
dc.subject | PATIENTS | |
dc.subject | PAYMENT TERMS | |
dc.subject | PHARMACEUTICAL | |
dc.subject | PHARMACEUTICAL CONSUMPTION | |
dc.subject | PHARMACEUTICAL DISPENSING | |
dc.subject | PHARMACEUTICAL DISTRIBUTION | |
dc.subject | PHARMACEUTICAL DISTRIBUTION NETWORKS | |
dc.subject | PHARMACEUTICAL INDUSTRY | |
dc.subject | PHARMACEUTICAL MANUFACTURERS | |
dc.subject | PHARMACEUTICAL MANUFACTURING | |
dc.subject | PHARMACEUTICAL POLICY | |
dc.subject | PHARMACEUTICAL PRODUCTION | |
dc.subject | PHARMACEUTICAL PRODUCTS | |
dc.subject | PHARMACEUTICAL SECTOR | |
dc.subject | PHARMACEUTICAL SERVICES | |
dc.subject | PHARMACEUTICAL SUPPLIERS | |
dc.subject | PHARMACEUTICAL SUPPLIES | |
dc.subject | PHARMACEUTICAL SUPPLY | |
dc.subject | PHARMACIES | |
dc.subject | PHARMACISTS | |
dc.subject | PHARMACOLOGY | |
dc.subject | PHARMACY | |
dc.subject | PHARMACY PRACTICES | |
dc.subject | PILL | |
dc.subject | POOLED PROCUREMENT | |
dc.subject | PRESCRIPTIONS | |
dc.subject | PRIVATE PHARMACIES | |
dc.subject | PRIVATE SECTOR | |
dc.subject | PRIVATE SECTORS | |
dc.subject | PROCUREMENT | |
dc.subject | PRODUCT MARKET | |
dc.subject | PRODUCT PRICING | |
dc.subject | PRODUCT QUALITY | |
dc.subject | PUBLIC EDUCATION | |
dc.subject | PUBLIC HEALTH | |
dc.subject | PURCHASING | |
dc.subject | PURCHASING POWER | |
dc.subject | QUALITY ASSURANCE | |
dc.subject | QUALITY CONTROL | |
dc.subject | QUALITY OF SERVICES | |
dc.subject | QUININE | |
dc.subject | RADIO | |
dc.subject | RADIO-FREQUENCY IDENTIFICATION | |
dc.subject | REGULATORY AUTHORITIES | |
dc.subject | REGULATORY ENVIRONMENT | |
dc.subject | REGULATORY FRAMEWORK | |
dc.subject | REGULATORY FRAMEWORKS | |
dc.subject | RESULT | |
dc.subject | RESULTS | |
dc.subject | RETAIL | |
dc.subject | RETAIL OUTLETS | |
dc.subject | RETAIL PHARMACIES | |
dc.subject | RETAIL PRICES | |
dc.subject | RETAIL SALES | |
dc.subject | RETAILING | |
dc.subject | SALES | |
dc.subject | SERVICE DELIVERY | |
dc.subject | SERVICE PROVIDERS | |
dc.subject | SITES | |
dc.subject | SPREAD | |
dc.subject | STOCK MANAGEMENT | |
dc.subject | STOCKS | |
dc.subject | STORAGE FACILITIES | |
dc.subject | STORAGE SPACE | |
dc.subject | SUBSTITUTION | |
dc.subject | SUPERVISION | |
dc.subject | SUPPLIER | |
dc.subject | SUPPLIERS | |
dc.subject | SUPPLY CHAIN | |
dc.subject | SUPPLY CHAIN MANAGEMENT | |
dc.subject | SUPPLY CHAIN MANAGEMENT SYSTEM | |
dc.subject | SUPPLY CHAIN OPERATIONS | |
dc.subject | SUPPLY CHAINS | |
dc.subject | SUPPLY MANAGEMENT | |
dc.subject | SUPPLY NETWORKS | |
dc.subject | SUPPLY OF RAW MATERIALS | |
dc.subject | TABLETS | |
dc.subject | TARGETS | |
dc.subject | TECHNICAL STAFF | |
dc.subject | THERAPIES | |
dc.subject | TRADITIONAL MEDICINES | |
dc.subject | TRANSPORT SYSTEM | |
dc.subject | TURNOVER | |
dc.subject | USER | |
dc.subject | USER FEES | |
dc.subject | USERS | |
dc.subject | VACCINES | |
dc.subject | VALUE CHAIN | |
dc.subject | VITAMINS | |
dc.subject | VOLATILITY | |
dc.subject | WAREHOUSE | |
dc.subject | WHOLESALE PRICES | |
dc.subject | WHOLESALER | |
dc.subject | WHOLESALERS | |
dc.subject | WHOLESALING | |
dc.subject | WORKERS | |
dc.subject | WORKING CAPITAL | |
dc.title | Private Sector Pharmaceutical Supply and Distribution Channels in Africa : A Focus on Ghana, Malawi and Mali | en |
dspace.entity.type | Publication | |
okr.date.disclosure | 2011-11-15 | |
okr.date.doiregistration | 2025-05-05T11:46:49.384251Z | |
okr.doctype | Publications & Research::Working Paper | |
okr.doctype | Publications & Research | |
okr.docurl | http://documents.worldbank.org/curated/en/2011/08/15476296/private-sector-pharmaceutical-supply-distribution-channels-africa-focus-ghana-malawi-mali | |
okr.globalpractice | Macroeconomics and Fiscal Management | |
okr.globalpractice | Transport and ICT | |
okr.globalpractice | Finance and Markets | |
okr.globalpractice | Trade and Competitiveness | |
okr.guid | 756351468194341354 | |
okr.identifier.externaldocumentum | 000386194_20111115235716 | |
okr.identifier.internaldocumentum | 15476296 | |
okr.identifier.report | 65601 | |
okr.language.supported | en | |
okr.pdfurl | http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2011/11/15/000386194_20111115235716/Rendered/PDF/656010WP00PUBL00PvtSectorPharma0811.pdf | en |
okr.region.administrative | Africa | |
okr.region.country | Ghana | |
okr.region.country | Malawi | |
okr.region.country | Mali | |
okr.topic | International Economics and Trade::Access to Markets | |
okr.topic | Private Sector Development::E-Business | |
okr.topic | Health Monitoring and Evaluation | |
okr.topic | Macroeconomics and Economic Growth::Markets and Market Access | |
okr.topic | Pharmaceuticals and Pharmacoeconomics | |
okr.topic | Health | |
okr.topic | Nutrition and Population | |
okr.unit | Health, Nutrition & Population (AFTHE) | |
okr.volume | 1 of 1 | |
relation.isAuthorOfPublication | 8d6fe777-ecd9-594f-ad71-6caae07af3f6 | |
relation.isAuthorOfPublication | f0db8585-256f-5272-b725-a56ddc03f309 | |
relation.isAuthorOfPublication | e816a4d0-f11d-5e40-b9f1-a5463712b586 | |
relation.isAuthorOfPublication.latestForDiscovery | f0db8585-256f-5272-b725-a56ddc03f309 |
Files
License bundle
1 - 1 of 1